Hennion & Walsh Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.44M Buy
87,844
+21,602
+33% +$666K 0.1% 259
2026
Q1
$1.79M Buy
66,242
+14,053
+27% +$472K 0.06% 373
2025
Q4
$2.24M Buy
+52,189
New +$1.97M 0.08% 329

Other funds holding RIGL